Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Theravance, Inc. 

901 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-808-6000 Fax: 650-827-8690



 Company News
Theravance (THRX) Announces New Employment Inducement Awards 4/6/2015 10:16:43 AM
GlaxoSmithKline (GSK) And Theravance (THRX) Announce Outcome Of US FDA Advisory Committee On BREO ELLIPTA In Asthma 3/20/2015 11:19:41 AM
Theravance (THRX) Announces Trading In Common Stock Halted 3/20/2015 11:11:03 AM
FDA Panel Backs GlaxoSmithKline (GSK), Theravance (THRX)'s Breo for Adults, Not Kids 3/20/2015 6:13:37 AM
Theravance, Inc. (THRX) To Present At The Cowen and Company Healthcare Conference 2/26/2015 11:45:04 AM
Theravance, Inc. (THRX) Announces Cash Dividend Of $0.25 Per Share Payable To Stockholders Of Record As Of March 12, 2015 2/24/2015 12:32:06 PM
Theravance, Inc. (THRX) Reports Fourth Quarter And Full Year 2014 Financial Results 2/20/2015 10:43:31 AM
Theravance, Inc. (THRX) To Report Fourth Quarter And Full Year 2014 Financial Results On February 18, 2015 2/11/2015 3:23:02 PM
Theravance, Inc. (THRX) Announces FDA Advisory Committee To Review BREO(R) ELLIPTA(R) (FF/VI) For Asthma 2/11/2015 12:04:27 PM
GlaxoSmithKline (GSK) And Theravance, Inc. (THRX) Announce Start Of Phase 3 Lung Function Study With 'Closed' Triple Combination Treatment FF/UMEC/VI For COPD 2/9/2015 12:11:29 PM